wada aod9604 prohibited status 2025 just added tirzepatide (mounjaro) to the 2026 Monitoring Program The 2025 WADA List of
Description
This is so that you protect yourself and maintain the quality of the contents
Run once daily with gradual titration across the cycle
This plan starts with a loading phase and then moves to maintenance therapy
doi: 10.1016/0196-9781(89)90065-x 122 Sackmann-SalaLDingJFrohmanLAKopchickJJ
Serious cases can result in megaloblastic anemia, where the ill-formed red blood cells cant move from the bone marrow to circulation
Do not shake vials vigorously
